This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07596/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07596/identifier/pdb/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07596/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07596/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07596/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07596
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB07596 n14:DB07596
dcterms:title
(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate
adms:identifier
n7:DB07596 n8:CTF n11:9363982 n12:11188898 n13:99444067
n3:IUPAC-Name
n4:271B53BF-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B53C5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B53C4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B53C1-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B53C2-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B53C3-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B53BD-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B53BE-363D-11E5-9242-09173F13E4C5 n4:271B53BB-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B53BC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B53CB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B53CC-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B53C6-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B53C7-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B53C9-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B53C8-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B53CA-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B53D1-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B53D3-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B53D4-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B53D0-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B53CF-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B53D2-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B53C0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B53CD-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B53CE-363D-11E5-9242-09173F13E4C5